{"nct_id":"NCT03207256","title":"Extension Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials","status":"TERMINATED","status_verified_date":"2022-07","start_date":"2017-08-09","start_date_type":"ACTUAL","primary_completion_date":"2022-05-25","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TGTX"]}